Johnson Matthey PLC (LON:JMAT) Insider Buys £424.08 in Stock

→ #1 election stock (From Porter & Company) (Ad)

Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon acquired 24 shares of the stock in a transaction dated Wednesday, April 17th. The stock was purchased at an average cost of GBX 1,767 ($22.00) per share, with a total value of £424.08 ($527.92).

Johnson Matthey Stock Performance

Shares of Johnson Matthey stock traded down GBX 16 ($0.20) during trading hours on Thursday, hitting GBX 1,753 ($21.82). 281,033 shares of the company's stock traded hands, compared to its average volume of 694,900. Johnson Matthey PLC has a 12-month low of GBX 1,428.50 ($17.78) and a 12-month high of GBX 1,986.31 ($24.73). The stock has a market capitalization of £3.22 billion, a price-to-earnings ratio of 1,826.04, a PEG ratio of 49,242.50 and a beta of 0.98. The company has a fifty day simple moving average of GBX 1,702.30 and a 200-day simple moving average of GBX 1,625.82. The company has a debt-to-equity ratio of 63.95, a current ratio of 1.51 and a quick ratio of 0.76.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Numis Securities reissued a "buy" rating and set a GBX 2,200 ($27.39) target price on shares of Johnson Matthey in a research report on Wednesday, March 20th. Berenberg Bank increased their target price on Johnson Matthey from GBX 1,650 ($20.54) to GBX 1,800 ($22.41) and gave the stock a "hold" rating in a report on Monday, April 8th. Finally, Jefferies Financial Group reiterated a "buy" rating and issued a GBX 2,100 ($26.14) target price on shares of Johnson Matthey in a report on Wednesday, March 20th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of GBX 2,010 ($25.02).


View Our Latest Analysis on JMAT

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

See Also

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Should you invest $1,000 in Johnson Matthey right now?

Before you consider Johnson Matthey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.

While Johnson Matthey currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Featured Articles and Offers

Search Headlines: